 Document Security Systems, Inc. NYSE: DSS, subsidiary Impact Biomedical, Inc, along with its scientific research partner Global Research and Discovery Group Sciences, GRDG, announced encouraging results from clinical tests of its 3FDB DEET Booster technology. The results suggest that 3FDB can boost the effectiveness of mosquito repellants, specifically DEET. 